User profiles for G N Fuller

Gregory N. Fuller

Professor of Pathology, MD Anderson Cancer Center
Verified email at mdanderson.org
Cited by 46367

Sacral chordoma: 40-year experience at a major cancer center

JE York, A Kaczaraj, D Abi-Said, GN Fuller… - …, 1999 - journals.lww.com
OBJECTIVE: Sacral chordomas are relatively rare, locally invasive, malignant neoplasms.
Despite surgical resection, adjuvant radiation therapy, and chemotherapy, recurrence is …

RET oncogene activation in papillary thyroid carcinoma

G Tallini, SL Asa, GN Fuller - Advances in anatomic pathology, 2001 - journals.lww.com
The RET proto-oncogene encodes a cell membrane tyrosine-kinase receptor protein whose
ligands belong to the glial cell line–derived neurotrophic factor. RET functions as a …

Amplified cellular oncogenes in neoplasms of the human central nervous system

GN Fuller, SH Bigner - Mutation Research/Reviews in Genetic Toxicology, 1992 - Elsevier
… Although this classification scheme remains controversial (Burger and Fuller, 1991), we
will consider these neoplasms as a single rubric for the purposes of the present review. …

Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice

…, C Dai, L Schaefer, RE Sawaya, GN Fuller - Nature …, 2000 - nature.com
Gliomas are the most common primary malignant brain tumours and are classified into four
clinical grades 1, with the most aggressive tumours being grade 4 astrocytomas (also known …

Limitations of stereotactic biopsy in the initial management of gliomas

RJ Jackson, GN Fuller, D Abi-Said, FF Lang… - Neuro …, 2001 - academic.oup.com
Stereotactic biopsy is often performed for diagnostic purposes before treating patients whose
imaging studies highly suggest glioma. Indications cited for biopsy include diagnosis and/…

PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo

…, Y Okada, DN Louis, GN Fuller… - Genes & …, 2001 - genesdev.cshlp.org
We present evidence that some low-grade oligodendrogliomas may be comprised of proliferating
glial progenitor cells that are blocked in their ability to differentiate, whereas malignant …

cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading

…, C Eberhart, D Figarella‐Branger, M Fouladi, GN Fuller… - 2020 - Wiley Online Library
cIMPACT‐NOW (the Consortium to Inform Molecular and Practical Approaches to CNS Tumor
Taxonomy) was established to evaluate and make practical recommendations on recent …

Malignant gliomas: MR imaging spectrum of radiation therapy-and chemotherapy-induced necrosis of the brain after treatment

AJ Kumar, NE Leeds, GN Fuller, P Van Tassel… - Radiology, 2000 - pubs.rsna.org
PURPOSE: To describe both the common and less frequently encountered magnetic
resonance (MR) imaging features of radiation therapy– and chemotherapy-induced brain injury, …

I nternational S ociety of N europathology‐H aarlem C onsensus G uidelines for N ervous S ystem T umor C lassification and G rading

…, C Eberhart, D Figarella‐Branger, GN Fuller… - Brain …, 2014 - Wiley Online Library
Major discoveries in the biology of nervous system tumors have raised the question of how
non‐histological data such as molecular information can be incorporated into the next W orld …

[HTML][HTML] Phase I study of DNX-2401 (Delta-24-RGD) oncolytic adenovirus: replication and immunotherapeutic effects in recurrent malignant glioma

…, SS Prabhu, G Rao, GN Fuller… - Journal of clinical …, 2018 - ncbi.nlm.nih.gov
Purpose DNX-2401 (Delta-24-RGD; tasadenoturev) is a tumor-selective, replication-competent
oncolytic adenovirus. Preclinical studies demonstrated antiglioma efficacy, but the effects …